MP58-07 THE IMPACT OF 3D MODELS ON SURGICAL OUTCOMES OF RAPN: IS CT SCAN BECOMING OBSOLETE?

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP58-07 THE IMPACT OF 3D MODELS ON SURGICAL OUTCOMES OF RAPN: IS CT SCAN BECOMING OBSOLETE? Luigi Nocera, Carlo Bravi, Angelo Mottaran, Adele Piro, Luca Sarchi, Marco Paciotti, Maria Peraire Lores, Eleonora Balestrazzi, Federico Piramide, Rui Farinha, Pieter De Backer, Ruben De Groote, and Alexandre Mottrie Luigi NoceraLuigi Nocera More articles by this author , Carlo BraviCarlo Bravi More articles by this author , Angelo MottaranAngelo Mottaran More articles by this author , Adele PiroAdele Piro More articles by this author , Luca SarchiLuca Sarchi More articles by this author , Marco PaciottiMarco Paciotti More articles by this author , Maria Peraire LoresMaria Peraire Lores More articles by this author , Eleonora BalestrazziEleonora Balestrazzi More articles by this author , Federico PiramideFederico Piramide More articles by this author , Rui FarinhaRui Farinha More articles by this author , Pieter De BackerPieter De Backer More articles by this author , Ruben De GrooteRuben De Groote More articles by this author , and Alexandre MottrieAlexandre Mottrie More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003311.07AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Since their inception 3D virtual models have helped clinician in surgical indication and preoperative planning, as well as in intraoperative guidance. The added value of 3D models was particularly true in robot-assisted partial nephrectomy (RAPN) given the wide spectrum of possible tumor locations and anatomical variants. We aimed to examine the impact of 3D virtual models on surgical outcomes in a tertiary referral center. METHODS: We relied on 474 patients in our prospectively maintained renal cancer database treated with RAPN between 2009 and 2021. Patients harbouring multiple masses were excluded. The endpoints of the analyses were: 1) presence of positive surgical margins (PSM); 2) warm ischemia time (WIT) and 3) length of stay (LOS). Multivariable regressions examined the impact of the use of 3D virtual model on PSM, WIT and LOS. For all models, the adjustment for casemix included: age, sex, tumor size, tumor side, clinical T stage, PADUA score and estimated blood loss (EBL). RESULTS: Overall, median age was 64 years (interquartile range [IQR]: 55, 73). Median (IQR) tumor size and PADUA score were 3.1 (2.1, 4.5) cm and 8 (7, 10), whereas tumor side was more frequently right (54%). Median WIT was 13 minutes (IQR: 6, 19). OR console time and blood loss were 120 minutes (IQR: 90, 150) and 200 ml (IQR: 100-300), respectively. Median LOS was 3 days (IQR: 3, 5) and 7% of patients had PSM on final pathology. A 3D model was reconstructed for 84 (18%) patients. Patients with reconstructed 3D virtual models had more complex tumors (median PADUA score 9 vs. 8, p<0.05). No other statistically significant differences were recorded, although patients with available 3D models were older (66 vs. 64 years), less frequently male (63% vs. 71%), and exhibited longer WIT (14 vs. 13 minutes), shorter LOS (3 vs. 4 days) and lower PSM rate (3.6% vs 7.4%) (all p>0.05). On multivariable logistic regression models, 3D virtual model usage was an independent predictor of lower PSM rate (odds ratio [OR]: 0.27; p<0.05). Similarly, on multivariable Poisson regressions, 3D virtual model usage was an independent predictor of shorter WIT (OR 0.78; p<0.05) and shorter LOS (OR: 0.82; p<0.01). CONCLUSIONS: Our findings suggest a potentially crucial role of 3D virtual reconstructions for candidates to RAPN for both surgical planning and intraoperative guidance. Indeed, the use of 3D virtual models led to an improvement of potentially both oncological (reduction in PSM) and functional outcomes (reduction in WIT). Further studies are required to confirm these findings at long-term follow-up. Source of Funding: none © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e798 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Luigi Nocera More articles by this author Carlo Bravi More articles by this author Angelo Mottaran More articles by this author Adele Piro More articles by this author Luca Sarchi More articles by this author Marco Paciotti More articles by this author Maria Peraire Lores More articles by this author Eleonora Balestrazzi More articles by this author Federico Piramide More articles by this author Rui Farinha More articles by this author Pieter De Backer More articles by this author Ruben De Groote More articles by this author Alexandre Mottrie More articles by this author Expand All Advertisement PDF downloadLoading ...